Stay updated on Adjunctive Pimavanserin in MDD with Inadequate Response Clinical Trial
Sign up to get notified when there's something new on the Adjunctive Pimavanserin in MDD with Inadequate Response Clinical Trial page.

Latest updates to the Adjunctive Pimavanserin in MDD with Inadequate Response Clinical Trial page
- Check4 days agoChange DetectedNew revision entry v3.3.3 was added to the record history; the HHS Vulnerability Disclosure policy link and the older revision entry v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe history shows a new Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedThe Record History page now lists a new revision entry (v3.3.1) and removes the older revision (v3.2.0). This update is a metadata change to the version history rather than a modification of study data or content.SummaryDifference0.1%

- Check41 days agoChange DetectedThe notice about government funding lapse and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check55 days agoChange DetectedNew screenshot shows only cosmetic/layout changes to the Record History page, with no substantive updates to study status, text, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference11%

Stay in the know with updates to Adjunctive Pimavanserin in MDD with Inadequate Response Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in MDD with Inadequate Response Clinical Trial page.